105

Chipping Away at the Crisis (Part 2): Navigating Alzheimer’s from Diagnosis to Care with Dr. Jason Karlawish

Host Meryl Comer continues her conversation with Dr. Jason Karlawish, professor of medicine, medical ethics, and neurology at the University of Pennsylvania, about the evolving

LISTEN NOW
34

Rudy Tanzi and the Latest Alzheimer’s Drugs - part 1

Will 2023 be a boom or bust year for new Alzheimer’s drugs? 

In this episode of BrainStorm host Meryl Comer talks with Dr. Rudy Tanzi

LISTEN NOW
33

George Vradenburg – The Future of Alzheimer’s Advocacy Part 2

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowing Alzheimer's disease. What

LISTEN NOW
32

George Vradenburg and the Future of Alzheimer's Advocacy - Part 1

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowing Alzheimer's disease. What

LISTEN NOW
31

Ken Dychtwald - Breakthroughs at the Tipping Point

Rising longevity and the aging of boomers worldwide are radically altering both the demographic landscape and every aspect of our personal, social, financial, and political

LISTEN NOW
30

Dr. Larry Cahill – The Differences Between Female and Male Brains – part 2

Your brain controls and coordinates everything your body does from the movement of your fingers to your heart rate. It also plays a crucial role

LISTEN NOW